Alterola Biotech Inc
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailabil… Read more
Alterola Biotech Inc (ABTI) - Total Liabilities
Latest total liabilities as of September 2024: $3.62 Million USD
Based on the latest financial reports, Alterola Biotech Inc (ABTI) has total liabilities worth $3.62 Million USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Alterola Biotech Inc - Total Liabilities Trend (2009–2024)
This chart illustrates how Alterola Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Alterola Biotech Inc Competitors by Total Liabilities
The table below lists competitors of Alterola Biotech Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
FINMECCANICA - Dusseldorf Stock Exchang
DU:FMNB
|
Germany | €22.13 Billion |
|
E79 Resources Corp
OTCQB:ESVNF
|
USA | $13.38K |
|
Earthwise Minerals Corp.
F:966
|
Germany | €1.12 Million |
|
HOLOGIC
MU:HO1
|
Germany | €4.03 Billion |
|
DKSH HLDG N
MU:DS5
|
Germany | €3.73 Billion |
|
AKER -A-
BE:FKM
|
Germany | €37.96 Billion |
|
SYNAPTICS
BE:SJN
|
Germany | €1.32 Billion |
|
Bengal Energy Ltd
PINK:BNGLF
|
USA | $7.07 Million |
Liability Composition Analysis (2009–2024)
This chart breaks down Alterola Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.65 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Alterola Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Alterola Biotech Inc (2009–2024)
The table below shows the annual total liabilities of Alterola Biotech Inc from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-03-31 | $1.33 Million | -41.56% |
| 2023-09-30 | $2.28 Million | 0.00% |
| 2023-03-31 | $2.28 Million | +89.85% |
| 2022-09-30 | $1.20 Million | 0.00% |
| 2022-03-31 | $1.20 Million | +255.01% |
| 2021-09-30 | $338.49K | 0.00% |
| 2021-03-31 | $338.49K | +218.41% |
| 2020-09-30 | $106.31K | -68.59% |
| 2020-03-31 | $338.49K | +55.66% |
| 2019-09-30 | $217.45K | -26.21% |
| 2019-03-31 | $294.68K | +10.52% |
| 2018-09-30 | $266.63K | 0.00% |
| 2018-03-31 | $266.63K | -9.52% |
| 2017-09-30 | $294.68K | +10.52% |
| 2016-09-30 | $266.63K | +6.74% |
| 2016-03-31 | $249.78K | 0.00% |
| 2015-09-30 | $249.78K | +18.08% |
| 2015-03-31 | $211.54K | +17.80% |
| 2014-09-30 | $179.58K | 0.00% |
| 2014-03-31 | $179.58K | +66.47% |
| 2013-09-30 | $107.88K | +25.80% |
| 2011-03-31 | $85.75K | 0.00% |
| 2010-09-30 | $85.75K | +3510.53% |
| 2010-03-31 | $2.38K | 0.00% |
| 2009-09-30 | $2.38K | -- |